Literature DB >> 16902223

What works in schizophrenia: depot preparations may improve outcomes.

Peter M Haddad, Omair Niaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16902223      PMCID： PMC1539074          DOI： 10.1136/bmj.333.7563.353

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Systematic meta-review of depot antipsychotic drugs for people with schizophrenia.

Authors:  C E Adams; M K Fenton; S Quraishi; A S David
Journal:  Br J Psychiatry       Date:  2001-10       Impact factor: 9.319

2.  Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

Authors:  Jari Tiihonen; Kristian Wahlbeck; Jouko Lönnqvist; Timo Klaukka; John P A Ioannidis; Jan Volavka; Jari Haukka
Journal:  BMJ       Date:  2006-07-06

Review 3.  Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.

Authors:  E Lindström; K Bingefors
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

4.  Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.

Authors:  M Chakos; J Lieberman; E Hoffman; D Bradford; B Sheitman
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

5.  Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Authors:  M X Patel; V Nikolaou; A S David
Journal:  Psychol Med       Date:  2003-01       Impact factor: 7.723
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.